| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6183097 | Gynecologic Oncology | 2015 | 7 Pages |
Abstract
RO4929097 has insufficient activity as a single-agent in platinum-resistant ovarian cancer to warrant further study as monotherapy. Future studies are needed to explore the potential for cohort enrichment using NICD expression.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ivan Diaz-Padilla, Michelle K. Wilson, Blaise A. Clarke, Hal W. Hirte, Stephen A. Welch, Helen J. Mackay, Jim J. Biagi, Michael Reedijk, Johanne I. Weberpals, Gini F. Fleming, Lisa Wang, Geoffrey Liu, Chen Zhou, Chantale Blattler, S. Percy Ivy,